Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elental adjuvant S-1 trial in resected pancreatic cancer
jRCT1051180068Completed
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tegafur in pancreatic cancer (PC) (2 arms). Primary endpoint: Completion rate of S-1 adjuvant chemotherapy. Started Apr 2018; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT1051180068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051180068.